Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 11, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 14, 2026
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001493152-26-006833
Filed / recorded
Feb 14, 2026, 6:10 AM UTC
Added to OQRO
Oct 7, 2026, 11:38 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
PALISADE BIO, INC.
Issuer CIK
1357459
Ticker
PALI
Reporting person
Mitchell Lawrence Jones
Relationship
Officer
Officer title
Chief Medical Officer
Security
Restricted Stock Units
Table
Derivative (Table II)
Transaction date
Feb 11, 2026
Transaction code
M
Shares / units
8,000
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
16,000
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each RSU represents a contingent right to receive one share of the Issuer's common stock.
The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
4 tracked managers disclosed the same change for Q4 2025. From a 13F filed Feb 17, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.